Education
About Us
Working with TipRanks
Follow Us
Xtant Medical Holdings Inc (XTNT)
:XTNT
XTNT Stock Chart & Stats
$0.62
-$0.01(-2.65%)
At close: 4:00 PM EST
$0.62
-$0.01(-2.65%)
Day’s Range― - ―
52-Week Range$0.33 - $0.95
Previous CloseN/A
Volume57.26K
Average Volume (3M)279.05K
Market Cap
$103.60M
Enterprise Value$119.43M
Total Cash (Recent Filing)$10.40M
Total Debt (Recent Filing)$15.08M
Price to Earnings (P/E)68.8
Beta1.19
Next Earnings
Mar 05, 2026EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding140,004,240
10 Day Avg. Volume161,315
30 Day Avg. Volume279,046
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.50
P/FCF Ratio-3.70
Enterprise Value/Market Cap1.15
Enterprise Value/Revenue0.90
Enterprise Value/Gross Profit1.45
Enterprise Value/Ebitda10.96
Forecast
1Y Price Target
$1.50Price Target Upside141.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.03
Revenue Forecast (FY)$133.29M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthThe planned sale of Coflex, CoFix, and OUS Business strengthens XTNT's balance sheet, sheds a non-core group of assets, and reduces debt by approximately 50%.
EarningsXTNT generated adjusted EBITDA of $4.5M and improved its cash flow from operations.
Financial PerformanceXTNT reported revenue of $33.3M, slightly ahead of BTIG/Consensus estimates, as license revenue of $5.5M boosted results.
Bears Say
Product Segment PerformanceSpinal Implants revenue decreased by 19.9% year over year, impacting overall performance.
Xtant Medical Holdings News
XTNT FAQ
What was Xtant Medical Holdings Inc’s price range in the past 12 months?
Xtant Medical Holdings Inc lowest stock price was $0.33 and its highest was $0.95 in the past 12 months.
What is Xtant Medical Holdings Inc’s market cap?
Xtant Medical Holdings Inc’s market cap is $103.60M.
When is Xtant Medical Holdings Inc’s upcoming earnings report date?
Xtant Medical Holdings Inc’s upcoming earnings report date is Mar 05, 2026 which is in 83 days.
How were Xtant Medical Holdings Inc’s earnings last quarter?
Xtant Medical Holdings Inc released its earnings results on Nov 10, 2025. The company reported $0.009 earnings per share for the quarter, beating the consensus estimate of -$0.005 by $0.014.
Is Xtant Medical Holdings Inc overvalued?
According to Wall Street analysts Xtant Medical Holdings Inc’s price is currently Undervalued.
Does Xtant Medical Holdings Inc pay dividends?
Xtant Medical Holdings Inc does not currently pay dividends.
What is Xtant Medical Holdings Inc’s EPS estimate?
Xtant Medical Holdings Inc’s EPS estimate is >-0.01.
How many shares outstanding does Xtant Medical Holdings Inc have?
Xtant Medical Holdings Inc has 140,004,240 shares outstanding.
What happened to Xtant Medical Holdings Inc’s price movement after its last earnings report?
Xtant Medical Holdings Inc reported an EPS of $0.009 in its last earnings report, beating expectations of -$0.005. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Xtant Medical Holdings Inc?
Currently, no hedge funds are holding shares in XTNT
Xtant Medical Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.50 (141.94% Upside)
$1.50 (141.94% Upside)
Blogger Sentiment
Bullish
XTNT Sentiment 70%
Sector Average 68%
Sector Average 68%
Technicals
SMA
Positive
20 days / 200 days
Momentum
79.53%
12-Months-Change
Fundamentals
Return on Equity
3.64%
Trailing 12-Months
Asset Growth
7.52%
Trailing 12-Months
Company Description
Xtant Medical Holdings Inc
Xtant Medical Holdings (XTNT) is a medical technology company focused on developing and commercializing innovative solutions for the orthopedic and spinal surgery markets. The company specializes in regenerative medicine, offering a range of products including allograft tissue, spinal implants, and orthopedic surgical instruments designed to enhance patient outcomes and improve surgical efficiency. Xtant Medical operates primarily in the sectors of bone grafting and spinal surgery, positioning itself as a key player in the growing field of regenerative solutions.
XTNT Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a positive outlook with strong revenue growth, improved margins, and successful new product launches. However, there are some challenges in hardware revenue and slower than expected growth in the biologics product family. The pending asset sale is expected to further strengthen the company's financial position.View all XTNT earnings summariesXTNT Stock 12 Month Forecast
Average Price Target
$1.50
▲(141.94% Upside)
Technical Analysis
Ownership Overview
1.98% Insiders
2.07% Mutual Funds
54.09% Other Institutional Investors
40.37% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---